Department of Surgery, Division of Transplantation, Emory University School of Medicine, Atlanta, Georgia; Department of Medicine, Renal Division, Emory University School of Medicine, Atlanta, Georgia; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Department of Surgery, Division of Transplantation, Emory University School of Medicine, Atlanta, Georgia.
Am J Kidney Dis. 2022 Dec;80(6):707-717. doi: 10.1053/j.ajkd.2022.01.423. Epub 2022 Mar 14.
RATIONALE & OBJECTIVE: The national kidney allocation system (KAS) implemented in December 2014 in the United States redefined the start of waiting time from the time of waitlisting to the time of kidney failure. Waitlisting has declined post-KAS, but it is unknown if this is due to transplant center practices or changes in dialysis facility referral and evaluation. The purpose of this study was to assess the impact of the 2014 KAS policy change on referral and evaluation for transplantation among a population of incident and prevalent patients with kidney failure.
Cohort study.
SETTING & PARTICIPANTS: 37,676 incident (2012-2016) patients in Georgia, North Carolina, and South Carolina identified within the US Renal Data System at 9 transplant centers and followed through December 2017. A prevalent population of 6,079 patients from the same centers receiving maintenance dialysis in 2012 but not referred for transplantation in 2012.
KAS era (pre-KAS vs post-KAS).
Referral for transplantation, start of transplant evaluation, and waitlisting.
Multivariable time-dependent Cox models for the incident and prevalent population.
Among incident patients, KAS was associated with increased referrals (adjusted HR, 1.16 [95% CI, 1.12-1.20]) and evaluation starts among those referred (adjusted HR, 1.16 [95% CI, 1.10-1.21]), decreased overall waitlisting (adjusted HR, 0.70 [95% CI, 0.65-0.76]), and lower rates of active waitlisting among those evaluated compared to the pre-KAS era (adjusted HR, 0.81 [95% CI, 0.74-0.90]). Among the prevalent population, KAS was associated with increases in overall waitlisting (adjusted HR, 1.74 [95% CI, 1.15-2.63]) and active waitlisting among those evaluated (adjusted HR, 2.01 [95% CI, 1.16-3.49]), but had no significant impact on referral or evaluation starts among those referred.
Limited to 3 states, residual confounding.
In the southeastern United States, the impact of KAS on steps to transplantation was different among incident and prevalent patients with kidney failure. Dialysis facilities referred more incident patients and transplant centers evaluated more incident patients after implementation of KAS, but fewer evaluated patients were placed onto the waitlist. Changes in dialysis facility and transplant center behaviors after KAS implementation may have influenced the observed changes in access to transplantation.
2014 年 12 月在美国实施的国家肾脏分配系统(KAS)将等待时间的开始定义为从列入等候名单到肾衰竭的时间。KAS 后等待名单减少,但尚不清楚这是由于移植中心的做法还是透析机构的转诊和评估发生了变化。本研究的目的是评估 2014 年 KAS 政策变化对佐治亚州、北卡罗来纳州和南卡罗来纳州 9 个移植中心的新发病例和现患肾衰竭患者的转诊和评估的影响。
队列研究。
在 9 个移植中心内通过美国肾脏数据系统确定的 37676 名新发病例(2012-2016 年)患者,并随访至 2017 年 12 月。来自同一中心的 6079 名现患患者在 2012 年接受维持性透析,但在 2012 年未被转诊进行移植。
KAS 时代(KAS 前 vs KAS 后)。
转诊接受移植、开始移植评估和列入等候名单。
多变量时间依赖性 Cox 模型用于新发病例和现患患者。
在新发病例中,KAS 与转诊(调整后的 HR,1.16[95%CI,1.12-1.20])和转诊后评估开始(调整后的 HR,1.16[95%CI,1.10-1.21])增加、总体列入等候名单减少(调整后的 HR,0.70[95%CI,0.65-0.76]),以及与 KAS 前时期相比,接受评估的患者中活跃等候名单的比例较低(调整后的 HR,0.81[95%CI,0.74-0.90])。在现患患者中,KAS 与总体列入等候名单增加(调整后的 HR,1.74[95%CI,1.15-2.63])和接受评估的患者中活跃等候名单增加(调整后的 HR,2.01[95%CI,1.16-3.49])相关,但对接受转诊的患者的转诊或评估开始没有显著影响。
仅限于 3 个州,存在残余混杂。
在美国东南部,KAS 对肾衰竭新发病例和现患患者接受移植的影响不同。KAS 实施后,透析机构转诊的新发病例患者更多,移植中心评估的新发病例患者更多,但列入等候名单的评估患者更少。KAS 实施后透析机构和移植中心行为的变化可能影响了获得移植的情况。